SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Greystone Housing Impact Investors LP disclosed its financial results for the second quarter ended June 30, 2026, including a net loss of $1.52 million per BUC, Cash Available for Distribution of $0.10 per BUC, and total assets of $1.39 billion, with condensed consolidated statements of operations comparing Q2 2026 to Q2 2025 and six-month periods.
View raw filing on EDGAR →This is a clear earnings release disclosing Definitive Healthcare's Q2 2026 financial results for the quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents key financial metrics including revenue ($55.2M), net loss, adjusted net income, adjusted EBITDA, and cash flow, along with forward guidance for Q3 and full-year 2026. The Item 2.02 disclosure and attached press release are the hallmark of an earnings announcement, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 filed under Item 2.02. The disclosure includes condensed financial statements (balance sheet and statements of operations), cash position ($120.7 million), R&D and G&A expenses, net loss per share ($0.73), and business updates regarding the MGX-001 hemophilia A program. The press release is furnished as Exhibit 99.1 and contains both financial results and operational milestones typical of an earnings announcement.
View raw filing on EDGAR →ProKidney issued a press release on August 10, 2026, announcing financial results for the quarter ended June 30, 2026, with consolidated balance sheets, statements of operations, and cash flow statements attached as Exhibit 99.1. The disclosure includes Q2 2026 financial highlights (cash position of $181.6 million, R&D expenses of $36.1 million, net loss of $46.4 million) and material business milestones (completion of accelerated approval efficacy analysis enrollment, appointment of Chief Technical Officer). This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →This is a straightforward earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results via a press release (Exhibit 99.1) that includes condensed statements of operations and balance sheets, net loss of $40.4 million ($0.54 per share), R&D and G&A expenses, cash position of $243.2 million, and financial guidance extending cash runway into 2029. The filing explicitly states "Nkarta, Inc. (the 'Company') will issue a press release announcing its financial results for the second quarter ended June 30, 2026."
View raw filing on EDGAR →This is a clear earnings release disclosing quarterly financial results for the period ended June 30, 2026. The press release reports net investment income of $0.36 per share, net income of $(0.09) per share, NAV per share of $17.82, and includes detailed financial statements and portfolio information. The Item 2.02 disclosure and attached Exhibit 99.1 are standard for quarterly earnings announcements by BDCs.
View raw filing on EDGAR →Repay Holdings Corporation issued a press release on August 10, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, reporting revenue of $100.7 million (33% growth), Adjusted EBITDA of $36.3 million, and Free Cash Flow of $27.4 million, along with full-year 2026 guidance.
View raw filing on EDGAR →This is a clear earnings release disclosing Surf Air Mobility's Q2 2026 financial results. The filing explicitly states "On August 10, 2026, Surf Air Mobility Inc. issued a press release announcing the Company's financial results for the quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly revenue ($29.5 million), net loss ($28.1 million), Adjusted EBITDA loss ($10.5 million), and forward guidance for Q3 and full-year 2026, all hallmarks of an earnings release.
View raw filing on EDGAR →Ceribell issued a press release on August 10, 2026 announcing financial results for the fiscal quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($28.1 million, up 33% YoY), gross margin (92%), net loss ($19.3 million), and updated full-year 2026 revenue guidance ($114–$117 million). This is a standard earnings release filed under Item 2.02 with financial statements and forward-looking guidance, materially affecting investor assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →Perspective Therapeutics disclosed Q2 2026 financial results for the quarter ended June 30, 2026, reporting a net loss of $26.8 million ($0.22 per share), R&D expenses of $21.5 million, G&A expenses of $7.8 million, and a cash position of $237 million. The disclosure includes condensed consolidated financial statements and business highlights with clinical program updates.
View raw filing on EDGAR →AST SpaceMobile issued a press release on August 10, 2026 announcing Q2 2026 financial results, disclosing revenue of $31.5 million, operating expenses of $329.1 million, and a cash position of approximately $2.7 billion as of June 30, 2026, along with full-year 2026 revenue guidance of $150.0–$200.0 million.
View raw filing on EDGAR →Bain Capital Specialty Finance disclosed Q2 2026 financial results ended June 30, 2026, reporting net investment income per share of $0.44, net income per share of $0.22, and net asset value per share of $16.65, with consolidated financial statements included.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (ended July 4, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including net sales of $231.9 million (up 9% YoY), diluted EPS of $0.66 (up 94%), adjusted diluted EPS of $0.88 (up 49%), and raised full-year 2026 outlook. The company also highlights operational achievements including record operating cash flow, margin expansion, and capital returns to shareholders.
View raw filing on EDGAR →FiscalNote disclosed Q2 2026 financial results on August 10, 2026, via press release furnished as Exhibit 99.1. The filing reports total revenues of $19.6 million (in line with guidance), adjusted EBITDA of $2.3 million (slightly below guidance), and includes a material $19.1 million goodwill impairment charge. The company also revised full-year 2026 guidance downward from $80–$83M to $75–$78M in revenues and from $14–$16M to $9–$11M in adjusted EBITDA, reflecting softness in federal and public sector spending. This is a standard quarterly earnings release with material guidance revisions and impairment charges.
View raw filing on EDGAR →Item 2.02 discloses Apollo Commercial Real Estate Finance's financial results for the quarter ended June 30, 2026, with a summary press release and detailed presentation attached as exhibits. The filing reports net income of $0.11 per diluted share, Distributable Earnings metrics, and significant portfolio activity including the completed sale of the company's commercial real estate loan portfolio to Athene Holding Ltd. This is a standard quarterly earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →EagleRock issued a press release on August 10, 2026 disclosing financial results for the quarter ended June 30, 2026, including revenue of $41.5 million, normalized revenue of $46.8 million (up 32.3% QoQ), normalized adjusted EBITDA of $36.2 million, and full-year 2026 guidance of $129–$133 million normalized EBITDA.
View raw filing on EDGAR →This is a straightforward earnings release for Q2 2026 financial results. The Item 2.02 disclosure explicitly states that "Oruka Therapeutics, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains condensed consolidated balance sheets and statements of operations showing Q2 2026 results (net loss of $41.2 million vs. $24.6 million in Q2 2025) along with a corporate update on pipeline progress.
View raw filing on EDGAR →This is a press release disclosing unaudited financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of US$228.8 million, net loss of US$92.3 million, and Adjusted EBITDA of US$31.1 million. The document explicitly states "Bitdeer Reports Unaudited Financial Results for the Second Quarter of 2026" and provides detailed P&L, operational metrics, and MD&A analysis typical of a quarterly earnings release. Material to investors assessing the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →MoonLake disclosed second quarter 2026 financial results via press release dated August 10, 2026, reporting cash position of $537.0 million, R&D expenses of $50.2 million, G&A expenses of $11.4 million, and cash runway to mid-2028. The press release also announced positive topline Week 16 results from the Phase 3 IZAR-1 trial of sonelokimab in psoriatic arthritis, meeting all clinical endpoints.
View raw filing on EDGAR →This is a straightforward earnings release for Jerash Holdings' fiscal 2027 first quarter ended June 30, 2026. The filing discloses record revenue of $50.2 million (up 26.7%), gross profit of $8.3 million (up 35.7%), and net income of $1.7 million (up more than fivefold), along with detailed financial statements and forward guidance. The press release is furnished as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses financial results including net revenue of $51 thousand, operating expenses, and net loss of $7.3 million, along with key operational milestones (FDA PMA submission, clinical trial data). The filing includes condensed consolidated balance sheets and is material to investors assessing the company's financial position and progress toward commercialization of its Acclaim cochlear implant.
View raw filing on EDGAR →This is a press release dated August 10, 2026, announcing Alpha Tau's second quarter 2026 financial results, including R&D expenses of $20.9M, net loss of $68.8M ($0.76 per share), and cash balance of $104.8M. The release also discloses significant clinical and corporate milestones (REGAIN glioblastoma trial results, ReSTART enrollment completion, Tolmar partnership with $20M equity investment and $161.5M in milestone payments). While the exhibit bundles multiple announcements, the primary disclosure is the quarterly financial results with accompanying operational updates, making this an earnings release.
View raw filing on EDGAR →RUM Group Inc. issued a press release on August 10, 2026 announcing Q2 2026 financial results with record quarterly revenue of $40.4 million (up 61% year-over-year), detailed expense information, and initiated Q3 2026 revenue guidance of $87–$93 million.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (three months ended June 30, 2026) filed under Item 2.02 Results of Operations and Financial Condition. The press release discloses quarterly financial results including revenue of $5.6 million (up from $61 thousand in Q2 2025), net loss of $11.8 million, and key operational metrics. The filing includes condensed consolidated statements of operations and balance sheets as exhibits, which are standard components of an earnings disclosure. This is material to investors as it reports the company's financial performance and position.
View raw filing on EDGAR →Kayne Anderson BDC reported quarterly financial results for the period ended June 30, 2026, including net investment income of $27.5 million ($0.42 per share) and net asset value of $16.00 per share, along with portfolio metrics.
View raw filing on EDGAR →Purple Innovation issued a press release on August 10, 2026, announcing Q2 2026 financial results (net revenue of $98.3 million, GAAP net loss of $3.2 million, adjusted EBITDA of $2.1 million) and revised full-year 2026 revenue guidance to $420–$440 million. This is a standard quarterly earnings disclosure under Item 2.02, with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →This is Embraer's 2nd Quarter 2026 earnings results disclosure, presented as a comprehensive earnings release with detailed financial statements, operational metrics, and forward guidance. The document explicitly states "2nd QUARTER 2026 EARNINGS RESULTS" and includes consolidated revenue of US$2,235 million (+23% yoy), Adjusted EBIT of US$296.9 million with 13.3% margin, and updated 2026 guidance raising Adjusted EBIT margin guidance from 8.7%-9.3% to 10.0%-10.6%. This is a material event affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →This 6-K furnishes Embraer's Q2 2026 financial results as a press release. The document discloses "Best Q2 revenue in the company's history (US$2.2 bn)," detailed segment revenues and EBIT margins, updated 2026 guidance (revenue US$8.2–8.5B, EBIT margin 10.0–10.6%, FCF >US$400M), and key operational metrics (65 aircraft deliveries, US$34.5B backlog). These are material quarterly earnings that would affect a reasonable investor's assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →This is a formal earnings release for the second quarter of 2026 (6M26) filed by EDENOR, Argentina's largest electricity distributor. The document presents comprehensive financial results including revenues (ARS 918.5 billion in 2Q26, +10% vs 2Q25), EBITDA (ARS 313.7 billion for 6M26), net profit (ARS 31.3 billion in 2Q26), operating expenses, capital expenditures, and detailed operating indicators. The company explicitly announces results and schedules a webcast for August 11, 2026, with CFO German Ranftl to discuss the 2Q26 results, which is typical of a formal earnings announcement.
View raw filing on EDGAR →Brookdale Senior Living announced second quarter 2026 financial results, reporting consolidated net income of $23 million (versus a $43 million loss in Q2 2025), Adjusted EBITDA of $122 million (4.3% growth), RevPAR growth of 8.2% year-over-year, and occupancy improvements of 230 basis points, along with full-year 2026 guidance.
View raw filing on EDGAR →The Company issued a press release announcing consolidated operating results for Q2 and H1 2026, reporting net revenues of $424.0 million, net income from continuing operations of $81.9 million, and Adjusted EBITDA of $91.5 million, along with 2026 guidance of $320–$365 million in Subsidiary Adjusted EBITDA.
View raw filing on EDGAR →Palisade Bio issued a press release on August 10, 2026 announcing financial results for the three and six months ended June 30, 2026, including condensed consolidated balance sheets, statements of operations, and cash flow statements. The disclosure includes key financial metrics (net loss of $10.6 million for Q2 2026 vs. $2.8 million for Q2 2025, cash position of $125.2 million) and material operational updates on PALI-2108 Phase 2 development progress. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Green Dot Corporation issued a press release on August 10, 2026 announcing its financial results for the quarter ended June 30, 2026, including consolidated revenue of $595.9 million, net loss of $2.1 million, and adjusted EBITDA of $40.2 million. The disclosure is furnished as Exhibit 99.01 and constitutes a standard quarterly earnings release under Item 2.02, with detailed segment results and key business metrics.
View raw filing on EDGAR →This is a clear earnings release disclosing Bionano's Q2 2026 financial results for the period ended June 30, 2026. The press release reports total revenue of $8.2 million (21% YoY increase), consumables revenue of $4.3 million (31% increase), gross margin of 53%, and provides forward guidance for Q3 and full-year 2026. The filing is properly classified under Item 2.02 (Results of Operations and Financial Condition) with the full press release attached as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02. The disclosure includes total revenues of $29.0 million (up 13% YoY), licensing revenues of $18.2 million (up 21%, highest in three years), royalty revenues of $10.8 million, GAAP net loss of $2.9 million, and non-GAAP net income of $2.3 million. The earnings release is attached as Exhibit 99.1 and includes full financial statements and management commentary on business performance and market highlights.
View raw filing on EDGAR →Mesa Laboratories issued a press release on August 10, 2026 disclosing quarterly financial results for the three months ended June 30, 2026 (1Q27). The filing includes detailed revenue, operating income, net income, and divisional performance metrics, along with non-GAAP reconciliations and management commentary. This is a standard earnings release disclosure under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1.
View raw filing on EDGAR →HighPeak Energy issued a press release on August 10, 2026 announcing its second quarter 2026 financial and operating results, including net income of $82.3 million ($0.59 per diluted share), EBITDAX of $147.6 million, production volumes of 45.3 MBoe/d, and capital expenditures of $107.5 million.
View raw filing on EDGAR →CervoMed issued a press release on August 10, 2026, announcing financial results for the quarter ended June 30, 2026, including cash position ($24.9 million), R&D expenses ($4.3 million), G&A expenses ($2.4 million), and net loss ($6.6 million). The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes both financial results and material corporate updates (equity financings of $20.5 million, clinical trial progress, regulatory designations).
View raw filing on EDGAR →HireQuest issued a press release on August 10, 2026, reporting financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $8.1 million (up 6.0% YoY), net income of $2.7 million or $0.19 per diluted share (up from $0.08 in Q2 2025), and adjusted EBITDA of $4.6 million. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →Fluent, Inc. issued a press release on August 10, 2026 announcing second quarter 2026 financial results, including Q2 revenue of $48.4 million, net loss of $6.2 million, and key operational metrics for Commerce Media Solutions. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes consolidated financial statements and detailed segment performance, making it material to investors' assessment of the company's financial condition and operational performance.
View raw filing on EDGAR →FutureFuel Corp. issued a press release on August 10, 2026, announcing financial and operating results for Q2 and six months ended June 30, 2026. The disclosure includes detailed quarterly financial metrics (total revenues of $78.7 million, GAAP net income of $11.4 million, Adjusted EBITDA of $11.8 million), segment performance, and forward-looking guidance. This is a standard earnings release filed under Item 2.02 and furnished as Exhibit 99.1, which is material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →DiaMedica disclosed its condensed consolidated financial results for the quarter ended June 30, 2026, via a press release attached as Exhibit 99.1. The filing includes quarterly financial metrics (cash position of $43.5 million, net losses of $10.1 million and $20.2 million for Q2 and six months respectively), operating cash flows, and expense breakdowns by category (R&D, G&A). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial condition and runway.
View raw filing on EDGAR →Trump Media & Technology Group issued a press release on August 10, 2026, announcing its financial and operating results for the quarter ended June 30, 2026, disclosing a $238.1 million net loss, $1.7 million in revenue (up 89% year-over-year), total assets of $2.0 billion, and financial assets of $1.9 billion. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for earnings releases.
View raw filing on EDGAR →The filing discloses Dynamic Aerospace Systems' Q2 2026 financial results, reporting a GAAP net loss of $2.18 million for the quarter ended June 30, 2026. The shareholder letter from CEO Kent B. Wilson provides detailed financial performance metrics, including adjusted operational loss calculations and non-GAAP reconciliations. This constitutes a quarterly earnings release, which is material to investors assessing the company's financial condition and operational performance.
View raw filing on EDGAR →NESR reported Q2 2026 financial results with record revenue of $520.8 million (up 59.1% YoY), net income of $44.0 million (up 189.6% YoY), and diluted EPS of $0.43 (up 168.8% YoY), along with Adjusted EBITDA of $106.2 million (up 50.5% YoY) and strong cash flow generation.
View raw filing on EDGAR →The 8-K discloses Tonix Pharmaceuticals' second quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The press release reports Q2 2026 net product revenue of $13.5 million (vs. $2.0 million in Q2 2025), with TONMYA net sales of $11.0 million representing 197% quarter-over-quarter growth. The filing includes detailed financial metrics, operational highlights, and cash position ($176.2 million as of June 30, 2026), which are material to investors assessing the company's commercial execution and financial trajectory.
View raw filing on EDGAR →The 8-K discloses Sharplink's financial results for Q2 2026 (three and six months ended June 30, 2026) via Item 2.02 and an attached press release (Exhibit 99.1). The press release presents condensed consolidated balance sheets, statements of operations, revenue highlights ($11.5M in Q2 2026 vs. $0.7M in Q2 2025), net loss ($394.3M in Q2 2026 vs. $103.4M in Q2 2025), and operational metrics including ETH holdings and treasury strategy updates. This is a standard quarterly earnings disclosure material to investors assessing the registrant's financial condition and performance.
View raw filing on EDGAR →The filing discloses Outdoor Holding Company's financial results for the fiscal first quarter ended June 30, 2026, via Item 2.02 and an attached press release (Exhibit 99.1). The press release reports revenue growth of 22.1% to $14.5 million, return to profitability with net income from continuing operations of $3.6 million (versus a prior-year loss of $5.9 million), and Adjusted EBITDA more than doubling to $7.9 million. These are material quarterly earnings results that would affect a reasonable investor's assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →The 8-K discloses quarterly financial results for Q1 fiscal 2027 (quarter ended June 30, 2026) via Item 2.02, with a press release attached as Exhibit 99.1. The filing reports revenue of $110.8 million (6.4% growth), services revenue of $94.3 million (9.1% growth), improved operating cash flow, and updated full-year fiscal 2027 guidance. This is a standard earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →The 8-K discloses SHF Holdings' financial results for Q2 2026 via Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) announces Q2 2026 revenue of approximately $1.9 million (up 4.8% YoY), loan program income up 50.7% YoY, deposit balance growth of 6.8% YoY, and a net loss of approximately $(1.5) million. This is a standard quarterly earnings release with detailed financial statements and operational highlights, material to investors assessing the company's financial performance and strategic progress.
View raw filing on EDGAR →